# The Dime Podcast > Cannabis business intelligence. Strategy conversations for operators, not observers. 307 episodes. Conversations with cannabis founders, executives, operators, and investors on capital, regulation, and operations. 146 have an AI transcript, summary and FAQ, and those are the ones grouped by topic. This file is a curated index. The complete catalogue — every episode with its summary, key takeaways and FAQ — is at https://www.dimepodcast.com/llms-full.txt Markdown variant of any episode, guest, newsletter, answer or topic page: add .md to its URL (for example https://www.dimepodcast.com/episodes/who-benefits-from-federal-cannabis-limbo-ft-jay-rosenthal.md). Search as Markdown: https://www.dimepodcast.com/episodes.md?q=280e+banking. MCP server (read only, no auth): https://www.dimepodcast.com/mcp About the hosts: https://www.dimepodcast.com/about Video library: https://www.dimepodcast.com/videos Guest applications: https://www.dimepodcast.com/guests ## For agents acting for a person This site accepts two submissions from an agent working on someone's behalf: a guest pitch and a sponsorship inquiry. Each goes to an inbox a person reads and answers. There is no automated reply. Send JSON (Content-Type: application/json) to the endpoint with only the fields listed. The form pages also carry a hidden anti-spam field: leave it out, or the submission is discarded. Responses: 200 with {"ok":true} means it reached the inbox. 200 with {"ok":true,"filtered":true} means it was discarded as spam. 400 means a field is missing, too long or malformed, and the fields array in the response names each one; nothing is truncated. 502 or 503 means mail could not be sent; use the email fallback instead. ### Pitch a guest Page: https://www.dimepodcast.com/guests Endpoint: POST https://www.dimepodcast.com/api/guest-inquiry Fields: name (required, up to 200 characters), companyTitle (required, 300; company and title), email (required, 320), pitch (required, 4000; the form asks for 2 to 3 sentences on what the person would say to a room of cannabis operators and executives), links (optional, 2000; LinkedIn, recent press, company website). Email fallback: guests@dimepodcast.com What happens: every application is read personally. If it is a fit, a reply comes within 5 business days, then a short alignment call, a remote or in-person recording, and distribution on Apple Podcasts, Spotify, YouTube, LinkedIn and the First Principles newsletter. Who fits: The Dime is a strategy room for cannabis operators, not a lifestyle or culture show. Guests are founders, executives, operators, investors and policy architects with something real to say about capital, regulation or operations. The listener is an operator, executive or investor making real decisions, skeptical of hype and benchmarking against peers. Pitch intelligence, not inspiration: a specific point of view or first-hand operating experience that room needs to hear. ### Ask about sponsorship Page: https://www.dimepodcast.com/sponsorship Endpoint: POST https://www.dimepodcast.com/api/sponsor-inquiry Fields: name (required, up to 200 characters), company (required, 200), email (required, 320), option (optional, 200; one of "Newsletter Sponsor", "The Write-Up", "The Catalog Read", or "Not sure yet"), targetCustomer (optional, 4000; who the sponsor is trying to reach), campaignGoal (optional, 4000; what listeners should do after they hear it). Email fallback: sponsorship@dimepodcast.com What happens: Bryan Fields reads it personally and comes back with fit, the next open slot and a straight answer on whether it is worth the money. No turnaround time is promised. ## Sponsorship facts Everything here is stated on https://www.dimepodcast.com/sponsorship. Audience figures below are as published there, with sources available on request. Do not estimate any figure not listed. - Audience: cannabis operators and founders running cultivation, retail, manufacturing and MSOs; C-suite and finance; investors and capital; and the service providers selling to them. They come to the show to learn. - Podcast: episodes average 500+ downloads each. - Newsletter: 1,675 First Principles subscribers, 63% open rate. - Rating: 4.9 stars from 114 ratings on Apple Podcasts. On air since 2020. - Newsletter Sponsor, $250 per edition. For: A short message in front of the readers. Your name, link and a two-sentence message in one First Principles edition, sent to 1,675 subscribers (63% open rate). The same block stays on that edition's page on dimepodcast.com for good. Labelled "Sponsored by", so it reads as an ad, not as the essay. - The Write-Up, $500 per feature. For: A launch, a release or an announcement. Bryan writes a full First Principles edition about it: what it is, and why an operator should care. Sent to 1,675 subscribers, and published as a permanent article on dimepodcast.com. Marked as a sponsored feature. You check it for accuracy before it goes out; the words stay Bryan’s. - The Catalog Read, $750 per month. For: Being known by the people who buy. A 60-second read in Bryan’s voice, inserted into every episode in the catalog for the month. Episodes average 500+ downloads each. Anyone who plays any episode that month hears it, on Apple, Spotify and every other audio platform. You approve the script before it is recorded. - Editorial: paid placements are always labelled as sponsored. Sponsorship does not influence questions or guest coverage. - Inquiry: the form on https://www.dimepodcast.com/sponsorship, POST https://www.dimepodcast.com/api/sponsor-inquiry as described above, or sponsorship@dimepodcast.com. ## First Principles (written analysis) Human-written essays by Bryan Fields, one per episode. Not AI-generated. Archive: https://www.dimepodcast.com/newsletter The 8 most recent of 35. All of them: https://www.dimepodcast.com/llms-full.txt - [The Best Asset Is the One That Survives Being Wrong](https://www.dimepodcast.com/newsletter/the-best-asset-is-the-one-that-survives-being-wrong) (October 14, 2026): Reform does not help every cannabis operator equally. Jay Rosenthal on why the best asset is the one that still has value when your forecast is wrong. Episode: https://www.dimepodcast.com/episodes/who-benefits-from-federal-cannabis-limbo-ft-jay-rosenthal - [Your Brand Is the Experience. Consumers Expect It Again and Again.](https://www.dimepodcast.com/newsletter/your-brand-is-the-experience-consumers-expect-it-again-and-again) (October 6, 2026): The first purchase carries anticipation. The second carries expectation. Kim Sanchez Rael of Azuca on why every batch has to deliver the experience again. Episode: https://www.dimepodcast.com/episodes/what-makes-consumers-buy-the-same-edible-again-ft-kim-sanchez-rael - [Curaleaf x Aurora: Why EU-GMP Is the Hidden Asset in the Deal](https://www.dimepodcast.com/newsletter/curaleaf-aurora-why-eu-gmp-is-the-hidden-asset-in-the-deal) (September 22, 2026): Curaleaf's pursuit of Aurora isn't really about cannabis. It's about 50+ tons of EU-GMP supply and the two years it takes to build it from scratch. Episode: https://www.dimepodcast.com/episodes/stop-ignoring-germanys-massive-opportunity-europe-is-coming-ft-jamie-pearson - [The Cannabis Industry Fought for Medical Access. Why Is It Silent Now?](https://www.dimepodcast.com/newsletter/the-cannabis-industry-fought-for-medical-access-why-is-it-silent-now) (August 4, 2026): The federal hemp ban arrives in November. It was aimed at intoxicating products, but the language is broad enough to take therapeutic CBD with it. Episode: https://www.dimepodcast.com/episodes/paige-figi-the-cannabis-industry-is-cheering-a-ban-on-medicine - [The Cannabis Medical Thesis Was Never Wrong. The World Just Forgot.](https://www.dimepodcast.com/newsletter/the-cannabis-medical-thesis-was-never-wrong-the-world-just-forgot) (May 27, 2026): Cannabis started as a medical story, then the green rush buried it. The FDA's botanical drug pathway is what brings the original thesis back. Episode: https://www.dimepodcast.com/episodes/cannabis-was-medicine-now-the-proof-is-catching-up-ft-joel-stanley-and-dr-marcel-bonn-miller - [You Have Data. The Decisions Are Still Wrong](https://www.dimepodcast.com/newsletter/you-have-data-the-decisions-are-still-wrong) (May 11, 2026): Clean, organized data can still drive catastrophic decisions. The discount-spike loop that reads clearance as demand — and why it compounds. Episode: https://www.dimepodcast.com/episodes/the-hidden-margin-killer-for-msos-ft-braunz-muller - [The Payment Problem I Still Can't Explain](https://www.dimepodcast.com/newsletter/the-payment-problem-i-still-cant-explain) (April 13, 2026): Cannabis banking's hardest problem: compliance does not equal permission. Every payment solution runs on the card brands' tolerance. Episode: https://www.dimepodcast.com/episodes/the-legal-market-was-never-built-for-payments-why-cannabis-still-breaks-the-rules-ft-aubrey-amatelli - [Let's End the Year of the Prohibitionist.](https://www.dimepodcast.com/newsletter/lets-end-the-year-of-the-prohibitionist) (April 3, 2026): Access is a transaction. Influence is leverage. Cannabis has confused the two, and the scoreboard in Washington keeps saying so. Episode: https://www.dimepodcast.com/episodes/gretchen-gailey-cannabis-industry-has-no-idea-how-dc-works-why-rescheduling-is-delayed ## Answers (AI written column) Short answers to operator questions, drawn from the episode catalogue and citing it. Written by Isaac Burner, an AI analyst. Reviewed before publishing. Archive: https://www.dimepodcast.com/answers 11 answers, each listed with its question at https://www.dimepodcast.com/llms-full.txt ## Topics Full topic index: https://www.dimepodcast.com/topics Each topic has its own llms.txt: that topic's episodes, essays and answers, with an AI written brief when one exists. - [State Regulation](https://www.dimepodcast.com/topics/state-regulation): 72 episodes. Index: https://www.dimepodcast.com/topics/state-regulation/llms.txt - [Branding & Marketing](https://www.dimepodcast.com/topics/branding-and-marketing): 66 episodes. Index: https://www.dimepodcast.com/topics/branding-and-marketing/llms.txt - [Consumer Trends](https://www.dimepodcast.com/topics/consumer-trends): 66 episodes. Index: https://www.dimepodcast.com/topics/consumer-trends/llms.txt - [Cultivation & Extraction](https://www.dimepodcast.com/topics/cultivation-and-extraction): 60 episodes. Index: https://www.dimepodcast.com/topics/cultivation-and-extraction/llms.txt - [MSOs & Multi-State Operators](https://www.dimepodcast.com/topics/msos-and-multi-state-operators): 57 episodes. Index: https://www.dimepodcast.com/topics/msos-and-multi-state-operators/llms.txt - [Regulatory & Compliance](https://www.dimepodcast.com/topics/regulatory-and-compliance): 57 episodes. Index: https://www.dimepodcast.com/topics/regulatory-and-compliance/llms.txt - [Rescheduling & Federal Policy](https://www.dimepodcast.com/topics/rescheduling-and-federal-policy): 54 episodes. Index: https://www.dimepodcast.com/topics/rescheduling-and-federal-policy/llms.txt - [Data & Technology](https://www.dimepodcast.com/topics/data-and-technology): 48 episodes. Index: https://www.dimepodcast.com/topics/data-and-technology/llms.txt - [Retail & Dispensary Operations](https://www.dimepodcast.com/topics/retail-and-dispensary-operations): 38 episodes. Index: https://www.dimepodcast.com/topics/retail-and-dispensary-operations/llms.txt - [Medical & Research](https://www.dimepodcast.com/topics/medical-and-research): 33 episodes. Index: https://www.dimepodcast.com/topics/medical-and-research/llms.txt - [Supply Chain & Distribution](https://www.dimepodcast.com/topics/supply-chain-and-distribution): 33 episodes. Index: https://www.dimepodcast.com/topics/supply-chain-and-distribution/llms.txt - [International Markets](https://www.dimepodcast.com/topics/international-markets): 32 episodes. Index: https://www.dimepodcast.com/topics/international-markets/llms.txt - [M&A](https://www.dimepodcast.com/topics/manda): 23 episodes. Index: https://www.dimepodcast.com/topics/manda/llms.txt - [Taxation & 280E](https://www.dimepodcast.com/topics/taxation-and-280e): 20 episodes. Index: https://www.dimepodcast.com/topics/taxation-and-280e/llms.txt - [Capital Raising & Funding](https://www.dimepodcast.com/topics/capital-raising-and-funding): 18 episodes. Index: https://www.dimepodcast.com/topics/capital-raising-and-funding/llms.txt - [Banking & Payments](https://www.dimepodcast.com/topics/banking-and-payments): 13 episodes. Index: https://www.dimepodcast.com/topics/banking-and-payments/llms.txt - [Investor Perspective](https://www.dimepodcast.com/topics/investor-perspective): 12 episodes. Index: https://www.dimepodcast.com/topics/investor-perspective/llms.txt - [Labor & Workforce](https://www.dimepodcast.com/topics/labor-and-workforce): 11 episodes. Index: https://www.dimepodcast.com/topics/labor-and-workforce/llms.txt - [Litigation & Legal](https://www.dimepodcast.com/topics/litigation-and-legal): 11 episodes. Index: https://www.dimepodcast.com/topics/litigation-and-legal/llms.txt - [Real Estate](https://www.dimepodcast.com/topics/real-estate): 7 episodes. Index: https://www.dimepodcast.com/topics/real-estate/llms.txt - [Psychedelics & Mental Health](https://www.dimepodcast.com/topics/psychedelics-and-mental-health): 1 episode. Index: https://www.dimepodcast.com/topics/psychedelics-and-mental-health/llms.txt ## Recent episodes The 15 most recent. Full archive: https://www.dimepodcast.com/episodes Every episode, with takeaways and FAQ: https://www.dimepodcast.com/llms-full.txt - [Who Benefits From Federal Cannabis Limbo? ft. Jay Rosenthal](https://www.dimepodcast.com/episodes/who-benefits-from-federal-cannabis-limbo-ft-jay-rosenthal) — Jay Rosenthal: Jay Rosenthal, co-founder of the cannabis industry newsletter Cultivated, joins Bryan Fields to unpack why federal cannabis reform may actually benefit the biggest MSOs more than it threatens them,… - [What Makes Consumers Buy the Same Edible Again? ft. Kim Sanchez Rael](https://www.dimepodcast.com/episodes/what-makes-consumers-buy-the-same-edible-again-ft-kim-sanchez-rael) — Kim Sanchez Rael: In this episode, Bryan Fields talks with Kim Sanchez Rael of Azuca about why fast-onset edibles still make up only a small slice of the cannabis market despite clear consumer demand and premium… - [Europe Is Not a Rescue Plan ft. Jamie Pearson](https://www.dimepodcast.com/episodes/europe-is-not-a-rescue-plan-ft-jamie-pearson) — Jamie Pearson: This episode features international cannabis strategist Jamie Pearson breaking down why Europe is a medical, pharmaceutical-grade market rather than a quick escape hatch for struggling US operators,… - [Paige Figi: The Cannabis Industry Is Cheering A Ban On Medicine](https://www.dimepodcast.com/episodes/paige-figi-the-cannabis-industry-is-cheering-a-ban-on-medicine) — Paige Figi: In this episode, Paige Figi — mother of Charlotte Figi, whose story helped launch the modern medical CBD movement — breaks down the looming November 12th federal ban on hemp-derived CBD products and… - [Understand This Before You Use AI To Build Software ft. Chris Guthrie](https://www.dimepodcast.com/episodes/understand-this-before-you-use-ai-to-build-software-ft-chris-guthrie) — Chris Guthrie: Chris Guthrie of 365 Cannabis joins the podcast to explain why 'vibe coding' internal ERP, CRM, and supply-chain tools with AI is a tempting but dangerous shortcut for cannabis operators, arguing… - [Hirsh Jain: Rescheduling Is Already Picking Winners](https://www.dimepodcast.com/episodes/hirsh-jain-rescheduling-is-already-picking-winners) — Hirsh Jain: This episode features cannabis strategist Hirsh Jain unpacking the confusing reality behind the April 2025 rescheduling order — explaining why medical cannabis moved to Schedule III while adult-use… - [Germany Is the Engine: What BAT Knows That Cannabis Doesn't ft. James Yamanaka](https://www.dimepodcast.com/episodes/germany-is-the-engine-what-bat-knows-that-cannabis-doesnt-ft-james-yamanaka) — James Yamanaka: In this episode, Organigram CEO James Yamanaka discusses his path from British American Tobacco to leading one of Canada's largest cannabis companies, explaining how BAT's long-term, disciplined… - [Why Ohio Cannabis Is Built Different: Inside the Regulator-Operator Alignment That's Actually Working ft. Caroline Henry](https://www.dimepodcast.com/episodes/why-ohio-cannabis-is-built-different-inside-the-regulator-operator-alignment-thats-actually-working-ft-caroline-henry) — Caroline Henry: This episode features Caroline Henry of Buckeye Relief discussing why Ohio's slower, more deliberate approach to cannabis regulation — capped licensing, phased rule-making, and close collaboration… - [Cannabis Was Medicine. Now the Proof Is Catching Up, ft. Joel Stanley and Dr. Marcel Bonn-Miller](https://www.dimepodcast.com/episodes/cannabis-was-medicine-now-the-proof-is-catching-up-ft-joel-stanley-and-dr-marcel-bonn-miller) — Joel Stanley and Dr. Marcel Bonn-Miller: This episode features Joel Stanley, founding CEO of Charlotte's Web and now founder of Ozna Biosciences, and Dr. Marcel Bonn-Miller, a longtime cannabinoid researcher, discussing why proving cannabis… - [Joe Lustberg: What Cannabis Lenders See That Operators Miss](https://www.dimepodcast.com/episodes/joe-lustberg-what-cannabis-lenders-see-that-operators-miss) — Joe Lustberg: In this episode, Bryan Fields talks with Joe Lustberg of Upwise Capital about what cannabis lenders actually look for versus what operators assume matters, drawing on Joe's dual perspective as a… - [The Hidden Margin Killer for MSOS ft. Braunz Muller](https://www.dimepodcast.com/episodes/the-hidden-margin-killer-for-msos-ft-braunz-muller) — Braunz Muller: In this episode, Bryan Fields talks with Braunz Muller, former National Director of Manufacturing Operations at The Cannabist Company, about why cannabis manufacturers are drowning in data yet still… - [Ed Rosenthal and Greg Baughman: You're Still Growing Cannabis Wrong](https://www.dimepodcast.com/episodes/ed-rosenthal-and-greg-baughman-youre-still-growing-cannabis-wrong) — Ed Rosenthal & Greg Baughman: This episode features Ed Rosenthal, the legendary cannabis cultivation author, and Greg Baughman of CryoCure, discussing why cannabis post-harvest processes — drying, curing, storage, and… - [The Legal Market Was Never Built for Payments, Why Cannabis Still Breaks the Rules ft. Aubrey Amatelli](https://www.dimepodcast.com/episodes/the-legal-market-was-never-built-for-payments-why-cannabis-still-breaks-the-rules-ft-aubrey-amatelli) — Aubrey Amatelli: In this episode, PayRio founder Aubrey Amatelli explains why cannabis payment processing remains fundamentally unstable even for companies that follow every card-network rule, drawing on her own… - [Gretchen Gailey: Cannabis Industry Has No Idea How DC Works, Why Rescheduling Is Delayed](https://www.dimepodcast.com/episodes/gretchen-gailey-cannabis-industry-has-no-idea-how-dc-works-why-rescheduling-is-delayed) — Gretchen Gailey: Longtime Capitol Hill strategist Gretchen Gailey joins Bryan Fields to explain why the cannabis industry's Washington strategy is fundamentally broken, arguing that occasional fly-ins and small… - [15 Years of Cannabis Trading . Why I'll Sell Early (Unless This Happens) ft. Dan McDermitt](https://www.dimepodcast.com/episodes/15-years-of-cannabis-trading-why-ill-sell-early-unless-this-happens-ft-dan-mcdermitt) — Dan McDermitt: In this episode, 15-year cannabis stock trading veteran Dan McDermitt of ChartGuys joins host Bryan Fields to break down why the cannabis equity sector remains stuck despite years of rescheduling…